Indolent prostate cancer and active surveillance Sue Mayor 1 January 2010 Grandround 0 Number 34 Download pdf article Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article active surveillanceprostate cancer
Impact Factor For localised prostate cancer, does technology equal progress? Impact Factor 1 September 2012 0
Cover Story Pulling together: the case for prostate cancer units Cover Story, Featured 13 April 2016 0
Cutting Edge Active surveillance: the search for greater certainty Cutting Edge, Featured 31 October 2016 0
